Skip to main content
OpenTrials

Clinical trial condition

Bipolar I Disorder

Explore clinical trials studying Bipolar I Disorder. Study availability and eligibility vary by location and protocol.

110 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Bipolar I Disorder trial results

Recruiting

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

NCT07185815

Conditions
Bipolar I Disorder, Depressive Disorder, Depressive Disorder, Major, +5 more
Locations
  • Mapi Pharma Investigational Site IN-101 Ahmedabad, India
  • Mapi Pharma Investigational Site IN-102 Ahmedabad, India
  • Mapi Pharma Investigational Site IL-004 Beersheba, Israel
  • Mapi Pharma Investigational Site IL-003 Ness Ziona, Israel
View Trial Details
Recruiting

Children's Bipolar Network Treatment Trial I

NCT05427123

Conditions
Adolescent - Emotional Problem, Bipolar Disorder, Bipolar I Disorder, +8 more
Locations
  • University of California, Los Angeles, Max Gray Child and Adolescent Mood Disorders Program (CHAMP) Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus, Helen and Arthur E. Johnson Depression Center Aurora, Colorado, United States
  • University of Pittsburgh Child and Adolescent Bipolar Spectrum Services Clinic (CABS) Pittsburgh, Pennsylvania, United States
  • Virginia Commonwealth University Medical Center Richmond, Virginia, United States
View Trial Details
Recruiting

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

NCT05648591

Conditions
Bipolar I Disorder, Mental Disorders, Schizophrenia, +1 more
Locations
  • Vanda Investigational Site Little Rock, Arkansas, United States
  • Vanda Investigational Site Denver, Colorado, United States
  • Vanda Investigational Site Atlanta, Georgia, United States
  • Vanda Investigational Site Atlanta, Georgia, United States
View Trial Details
Enrolling by invitation

An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

NCT07217860

Conditions
Bipolar Depression, Bipolar Disorder, Bipolar I Disorder, +4 more
Locations
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Woodland Research Northwest Rogers, Arkansas, United States
  • ProScience Research Group Culver City, California, United States
  • PharmaSouth Research, LLC Coral Gables, Florida, United States
View all 20 locations
View Trial Details
Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

NCT04987229

Conditions
Bipolar I Disorder, Mental Disorders, Schizophrenia, +1 more
Locations
  • Alkermes Investigational Site Dothan, Alabama, United States
  • Alkermes Investigational Site Little Rock, Arkansas, United States
  • Alkermes Investigational Site Stanford, California, United States
  • Alkermes Investigational Site Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details

Related conditions